Furthermore, a recent analysis of Id1 expression from peripheral blood mononuclear cells of stage III and IV melanoma patients, strongly associates high Id1 levels with the presence of phenotypic and immunosuppressive markers in monocytic MDSCs, whereas low Id1 levels are associated with a more immunogenic myeloid phenotype (15). This evidence concerns the gene ID1 and melanoma.